cytidine monophosphate has been researched along with Anorexia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chida, N; Ono, T; Oohira, H; Sakata, Y; Suto, T; Yamada, N; Yoshida, T; Yoshida, Y | 1 |
Fukuoka, M; Hattori, M; Hirota, Y; Miyazaki, T; Nakamura, T; Niitani, H; Ohta, K; Suzuoki, Y; Tanaka, M; Yoshida, Y | 1 |
2 trial(s) available for cytidine monophosphate and Anorexia
Article | Year |
---|---|
[Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Anemia; Anorexia; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Thrombocytopenia | 1998 |
[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Vomiting | 1990 |